Health technology developers will for the next four weeks have a chance to influence the rules governing the joint scientific consultations (JSCs) that will help them prepare for EU-level joint clinical assessments, which go live from January.
HTA Regulation And Joint Scientific Consultations
The 2022 Health Technology Assessment Regulation aims to increase cooperation on HTA across Europe and lays the foundations for EU-level joint clinical assessments. These assessments will be similar to relative effectiveness assessments performed at member state level.
Joint scientific consultations (JSCs), which are also foreseen under the HTA Regulation, allow companies to seek scientific advice from the Member State Coordination Group on HTA during early clinical development
On 1 October, the European Commission published for consultation its draft implementing act on procedural rules for the JSCs
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?